BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22860241)

  • 21. Mirtazapine: a review of its use in major depression.
    Holm KJ; Markham A
    Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
    Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder.
    Wang D; Li Z; Li L; Hao W
    Asia Pac Psychiatry; 2014 Jun; 6(2):152-60. PubMed ID: 23857869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
    Lecei O; Lederbogen F; Gronau W; Scharnholz B; Terhardt J; Schilling C; Gilles M; Kopf D; Roth HJ; Weber-Hamann B; Deuschle M
    J Clin Psychopharmacol; 2012 Aug; 32(4):574-6. PubMed ID: 22760352
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability and safety aspects of mirtazapine.
    Nutt DJ
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-41. PubMed ID: 12404669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR; Nemeroff CB
    Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients.
    Shen J; Moller HJ; Wang X; Chung SA; Shapiro GK; Li X; Shapiro CM
    J Clin Psychiatry; 2009 Mar; 70(3):370-7. PubMed ID: 19192466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant treatment of the depressed patient with insomnia.
    Thase ME
    J Clin Psychiatry; 1999; 60 Suppl 17():28-31; discussion 46-8. PubMed ID: 10446739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
    Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression.
    Kang RH; Choi MJ; Paik JW; Hahn SW; Lee MS
    Int J Psychiatry Med; 2007; 37(3):315-29. PubMed ID: 18314859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mirtazapine: other indications.
    Falkai P
    J Clin Psychiatry; 1999; 60 Suppl 17():36-40; discussion 46-8. PubMed ID: 10446741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mirtazapine: a review of its use in major depression and other psychiatric disorders.
    Croom KF; Perry CM; Plosker GL
    CNS Drugs; 2009; 23(5):427-52. PubMed ID: 19453203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy.
    Kast RE
    Support Care Cancer; 2001 Sep; 9(6):469-70. PubMed ID: 11585276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
    Bech P
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):337-45. PubMed ID: 11806859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
    Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.
    Cankurtaran ES; Ozalp E; Soygur H; Akbiyik DI; Turhan L; Alkis N
    Support Care Cancer; 2008 Nov; 16(11):1291-8. PubMed ID: 18299900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.